XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Note Receivable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2020 $ 385,613 $ 69 $ 870,788 $ (16) $ 114 $ (485,342)
Beginning Balance, shares at Dec. 31, 2020   69,452,466        
Net loss (29,711)         (29,711)
Unrealized loss on investments (128)       (128) 0
Issuance of common stock under equity incentive and employee stock purchase plans 2,163 $ 1 2,162 0 0 0
Issuance of common stock under equity incentive and employee stock purchase plans, shares   370,987        
Repurchased shares upon vesting of restricted stock units for tax withholdings (5,013) $ 0 (5,013) 0 0 0
Repurchased shares upon vesting of restricted stock units for tax withholdings, shares   (80,960)        
Employee stock-based compensation 7,840 $ 0 7,840 0 0 0
Compensation expense related to options granted to consultants 240 0 240 0 0 0
Ending Balance at Mar. 31, 2021 361,004 $ 70 876,017 (16) (14) (515,053)
Ending Balance, shares at Mar. 31, 2021   69,742,493        
Beginning Balance at Dec. 31, 2021 $ 286,120 $ 70 903,646 (16) (483) (617,097)
Beginning Balance, shares at Dec. 31, 2021 70,357,557 70,357,557        
Net loss $ (38,608)         (38,608)
Unrealized loss on investments (1,372)       (1,372)  
Issuance of common stock upon net exercise of warrant   66,833        
Issuance of common stock under equity incentive and employee stock purchase plans 6,279 $ 1 6,278      
Issuance of common stock under equity incentive and employee stock purchase plans, shares   803,567        
Repurchased shares upon vesting of restricted stock units for tax withholdings (3,126)   (3,126)      
Repurchased shares upon vesting of restricted stock units for tax withholdings, shares   (85,855)        
Employee stock-based compensation 9,182   9,182      
Compensation expense related to options granted to consultants 244   244      
Ending Balance at Mar. 31, 2022 $ 258,719 $ 71 $ 916,224 $ (16) $ (1,855) $ (655,705)
Ending Balance, shares at Mar. 31, 2022 71,142,102 71,142,102